Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394446 · ClinicalTrials.gov registry record · Phase 1
Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors
A Phase 1 study, sponsored by Myrexis.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT00394446 is a Phase 1 study that has completed, run by Myrexis. The registered enrollment target is 48 participants.
The verdict
NCT00394446, a Phase 1 study, has completed, sponsored by Myrexis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
Phase 1, Multiple Dose Study of MPC-6827 in Subjects with Refractory Solid Tumors.
Interventions
- DRUG MPC-6827
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2005-03 |
| Est. Completion | 2008-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00394446
The ClinicalTrials.gov registry entry for NCT00394446 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Myrexis, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MPC-6827 is the first listed.
NCT00394446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00394446 about?
NCT00394446 is a clinical study titled "Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors". Phase 1, Multiple Dose Study of MPC-6827 in Subjects with Refractory Solid Tumors.
What is the current status of trial NCT00394446?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2005-03. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00394446?
The interventions under investigation include: MPC-6827 (DRUG).
Who is sponsoring clinical trial NCT00394446?
This trial is sponsored by Myrexis, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.